AdaptHealth (AHCO) Net Equity Issued and Repurchased (2021)

AdaptHealth (AHCO) posted quarterly Net Equity Issued and Repurchased of $278.8 million for Q1 2021.

AdaptHealth (AHCO) Net Equity Issued and Repurchased (2021) Analysis & Trends

AdaptHealth's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $278.8 million for Q1 2021.

In Q1 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $278.8 million; the TTM figure through Dec 2021 stood at $278.8 million (changed N/A YoY), while the FY2021 annual figure was $278.8 million, up 95.55% from the prior year.
Net Equity Issued and Repurchased for Q1 2021 stood at $278.8 million.
The five-year high for Net Equity Issued and Repurchased was $278.8 million in Q1 2021, with the low at $278.8 million in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Abbott Laboratories	199.46 Bn	193.86 Bn	7.27 Bn	-
2	Stryker	127.41 Bn	123.93 Bn	4.50 Bn	-
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	97.00 Mn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.95 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.35 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn	-
8	Koninklijke Philips	26.35 Bn	23.02 Bn	4.55 Bn	-
9	Steris	23.04 Bn	22.55 Bn	684.20 Mn	-
10	AdaptHealth	741.17 Mn	697.88 Mn	104.21 Mn	-

Download Data

Date	Value
Mar 31, 2021	278.85 Mn
Mar 31, 2021	278.85 Mn